Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Injectable Drug Delivery Partnering 2012-2018: Deal Trends, Players, Financials and Forecasts -

Research and Markets
Posted on: 22 Mar 18

The "Global Injectable Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts" report has been added to's offering.

Injectable Drug Delivery Partnering 2012-2018 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world's leading healthcare companies. This report provides details of the latest Injectable Drug Delivery agreements announced in the life sciences since 2012.

The report takes the reader through a comprehensive review Injectable Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Injectable Drug Delivery partnering deals.

The report presents financial deal term values for Injectable Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

One of the key highlights of the report is that over 280 online deal records of actual Injectable Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Injectable Drug Delivery technologies and products.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Injectable Drug Delivery dealmaking

Chapter 3 - Leading Injectable Drug Delivery deals

Chapter 4 - Most active Injectable Drug Delivery dealmakers

Chapter 5 - Injectable Drug Delivery contracts dealmaking directory

Chapter 6 - Injectable Drug Delivery dealmaking by technology type

Chapter 7 - Partnering resource center


Appendix 1 - Injectable Drug Delivery deals by company A-Z

Appendix 2 - Injectable Drug Delivery deals by stage of development

Appendix 3 - Injectable Drug Delivery deals by deal type

Appendix 4 - Injectable Drug Delivery deals by therapy area

Appendix 5 - Deal type definitions

For more information about this report visit

View source version on

Business Wire

Last updated on: 22/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.